The VA and prison population isn’t a large enough proportion of the addressable US HCV market to make as much difference as some people thought. In 1Q14, 90% of Sovaldi sales were from Medicare and private insurance (#msg-100954755, 4th bullet).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”